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The hydrolases aminopeptidase A and dipeptidyl peptidase 
IV, both present in the kidney on the brush borders of the 
proximal tubule epithelial cells and podocytes, are involved 
in the induction o f experimental membranous glomerulo­
nephritis in the mouse. However, little is known about their 
(co) distribution in other tissues and their function in health 
and disease. A detailed insight into the localization of these 
two enzymes is a prerequisite to elucidation of their func­
tion. Therefore, we investigated the presence and co-dis­
tribution o f aminopeptidase A and dipeptidyl peptidase 
IV by immunohistology with two different rat monoclonal 
antibodies, the specificity of which was determined by an 
immunodepletion technique. In addition, the molecular 
weight o f the hydrolases was analyzed by SDS-PAGE after
isolation by solid-phase immunoprécipitation from glomer­
uli, renal brush borders, and thymus. Both hydrolases showed 
different molecular weights in renal corpuscle, renal brush 
borders, and thymic cells, A widespread organ distribution 
of the two hydrolases was observed, with co-localization in 
kidney, liver, small intestine, thymus, brain, spleen, and 
lymph nodes, either on the same cells or on different cells 
in the same organ. This distribution and partial co-localiza­
tion suggests that the two hydrolases, acting either alone or 
in concert, have a role in many diverse biological processes.
( J Histochem Cytochem 44:445-461, 1996)
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Introduction
Antibodies that interact with intrinsic antigens on podocytes can 
induce a membranous glomerulonephritis, which can be used as 
an experimental model for the human form of this disease (1,2). 
O ne of these antigens which has extensively been studied in the 
rat is the Heymann antigen (3-5). However, this antigen is not pres­
ent on mouse podocytes and is therefore not involved in the devel­
opm ent of membranous glomerulonephritis in this species (6). We 
have found that two other antigens present on podocytes, i.e., the 
hydrolases aminopeptidase A (APA; EC 3.4.11.7) and dipeptidyl 
peptidase IV (DPP IV; EC 3.4.14.5), can participate as targets in 
the induction of a passive membranous glomerulonephritis in the 
mouse (6- 9). Both enzymes have also been reported to be involved 
in other experimental and human forms of nephropathy, such as 
the renal ablation model (10), passive anti-DPP IV nephritis (11-13), 
Heymann nephritis (14-16) in the rat, lupus nephritis in the mouse 
(17,18), and glomerulosclerosis (19), diabetic nephropathy (20), and 
chronic interstitial nephritis (21,22) in humans.
1 Supported by a grant from the Dutch Kidney Foundation (C91.1169).
2 Correspondence to: S. Mentzel, Dept, of Pathology, University Hos­
pita! Nijmegen, PO Box 9101, 6500 HB Nijmegen, The Netherlands.
Both APA and DPP IV are cell membrane-bound hydrolases, 
assumed to be involved in diverse biological processes such as pep­
tide degradation (23,24) and B- andT-cell differentiation (23,25). 
Previous studies have shown that APA and DPP IV are also present 
on various cell types of many organs other than the kidney. There­
fore, studies on the organ distribution of APA have been carried 
out in the rat and mouse with enzyme histochemical methods 
(26,27) and on a restricted number of organs in the mouse with 
a monoclonal antibody (MAb) against the BP1/6C3 antigen which 
was recently identified as APA (28). The organ distribution of DPP 
IV has been examined in a more or less restricted way in the mouse, 
rat, and rabbit by enzyme histochemistry (29) or immunohistol­
ogy using MAbs (13,30,31). Previously, we studied the localization 
of DPP IV in the mouse with polyclonal antibodies (6,8,31) that 
may lack the ultimate specificity of MAbs. In our laboratory we 
have generated a panel of rat MAbs to different antigens present 
on podocytes, several of which were directed to APA and DPP IV. 
For this study we selected two clones, ASD-4 and ASD-36, which 
bind respectively to APA and DPP IV (7). These two MAbs en­
abled us to study more thoroughly the organ distribution and puta­
tive co-localization of APA and DPP IV in the mouse. Because the 
functional roles o f the two enzymes are largely unknown, we stud­
ied the organ distribution of APA and DPP IV, thus looking in 
greater detail at their distribution in kidney and thymus.
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Materials and Methods
Animals. Balb/c and Balb/c, nu/nu mice were originally obtained from 
the Jackson Laboratory (Bar Harbor, ME) and were kept in the breeding 
farm facility of the Central Laboratory of Animals of our university by con­
tinuous brother-sister matings. Male Lou rats used for the production of 
MAbs were obtained from Harlan Olac (Blackthorn, Bicester, UK).
Preparation of Solubilized Suspensions from Renal Brush Borders, Re­
nal Corpuscles, and Thymus. An enriched suspension of mouse renal brush 
border membrane vesicles from proximal tubule epithelial cells was pre­
pared from Balb/c kidneys according to the method of Malathi et al. (32), 
using a 2-mM THs-HCl buffer, pH 7.2, containing 50 mM mannitol, the 
protease inhibitors EDTA (20 mM), PMSF (1 mM), benzamidine (1 mM), 
Trasylol (10 U/ml), and 0 ,02% NaN3 as described (7). The brush border 
suspension was solubilized with 2% Triton X414 in 50 mM Tris-HCl at 
4°C for 30 min and subjected to Triton X-114 phase separation at 37°C 
for 20 min, followed by centrifugation at 300 x g for 5 min (33). The 
obtained brush border preparation enriched in integral membrane pro­
teins served as immunogen for the production of MAbs. In the immuno­
précipitation procedure, a brush border fraction was used that was solubi­
lized with 1% sodium deoxycholate (brush border Doc) in 50 mM Tris-HCl, 
pH 8.5, with protease inhibitors and was subsequently centrifuged at 100,000 
x g for 1 hr at 4°C. For the fluorimetric enzyme assay, brush border'mem- 
brane vesicles were solubilized for 30 min at 4°C with 1% Doc in 50 mM 
Tris-HCl, pH  8.5, without protease inhibitors. Renal corpuscles were iso­
lated from kidneys of young Balb/c mice as previously described (34). The 
kidneys were perfused with ferric oxide and subsequently pushed through 
a 90-M.m pore size stainless steel sieve, after which the renal corpuscles were 
separated from other renal components with a magnet. The highly enriched 
renal corpuscle suspension, containing <5 % tubule or vascular fragments, 
was solubilized in 1% Doc and used in the immunoprécipitation. A com* 
pie te thymus from a young Balb/c mouse was solubilized in 1% Triton X-100. 
This preparation of solubilized thymic antigens was used in the immuno­
précipitation technique. Protein concentrations were determined by the 
method of Lowry (35).
Monoclonal Antibodies to APA and DPP IV, Male Lou rats were im­
munized IP with the detergent phase of the Triton X-114 extract of mouse 
brush border preparation, as described (7). Spleen cells from the Lou rats 
were fused with SP 2/0  mouse myeloma cells by the procedure of Kohler 
and Milstein (36). Hybridomas were grown in 96-well tissue culture plates 
(Costar; Cambridge, MA) with HEPES-buffered RPMI-1640 culture medium 
(MA Bioproducts; Bethesda, MD)t containing 10% decomplemented fetal 
calf serum, genramicin (40 jxg/ml), 1 mM kglutamine, 1 mM sodium pyru­
vate, and 10% supernatant o f  a human umbilical vein cell culture, sup­
plemented with HAT Hybridomas were selected for production of anti­
bodies to antigens present on both brush border membrane and podocytes 
by indirect immunofluorescence (IF) on acetone-fixed cryostat sections from 
normal mouse kidneys. Selected hybridomas were cloned several times by 
limiting dilution until all subclones showed the same reactivity pattern in 
the indirect IF screening procedure. Ascites containing MAbs was subse­
quently produced in Balb/c, nu /nu  mice, and was purified by ammonium 
sulfate precipitation. The MAbs coded ASD-4 and ASD-36 were selected 
for this study. The IgG content of the MAb preparations was measured 
by radial immunodiffusion (37). IgG subclasses were determined with an 
isotyping kit for rat MAbs according to the instructions of the manufac­
turer (Serotec; Oxford, UK), The test system is based on rat ceJl agglutina­
tion with highly specific antibodies directed to isotypes of rat IgG attached 
to sheep erythrocytes (38).
Immunoprécipitation, By a solid-phase immunoprécipitation proce­
dure (39), APA and DPP IV were isolated from suspensions of detergent
solubilized renal corpuscles (1% Doc), brush border vesicles (1% Doc), and 
thymus (1% Triton X-100) and were analyzed by SDS-PAGE. All three frac­
tions were radiolabeled with 125I (Amersham; Buckinghamshire, UK) using 
iodobeads (Pierce Chemical; Rockford, IL) as a coupling reagent (40). Free 
,25I was removed by Sephadex G-25 chromatography. Polystyrene microti- 
ter plates (Costar) were precoated with 10 jag/well affinity-purified goat 
anti-rat Ig antibodies (Cappel-Organon Teknika; Boxtel, The Netherlands) 
in PBS for 18 h at 4°C  After five washes with PBS containing 0.05% Tween, 
the wells were coated with 100 jil/well of purified ascites containing 10 mg 
Ig/ml of MAb for 3 hr at 37°C. After five further washes the wells were 
blocked for 3 hr at 21°C with PBS containing 1% BSA and 1% normal rat 
serum, and then again washed five times. The wells were next incubated 
for 2 hr at 2VC with the 125I-labeled kidney or thymic suspensions. The 
wells were then washed 10 times with immunoprécipitation (IP) buffer (150
mM NaCl, 50 mM Tris, 5 mM EDTA, 0 .1% Triton X-100, 0.02% SDS, 10 
U/ml Trasyîol, 1 mM PMSF, and 1 mM benzamidine; pH 7.4). Next, IQQ 
fil/weJl of reducing (2.3% SDS, 200 mM dithiothreitol, 10% glycerol, 60 
mM Tris-HCl, pH 6.8 ) or nonreducing (2.3% SDS, 10% glycerol, 60 mM 
Tris-HCl, pH 6 ,8) SDS sample buffer was added, after which the wells were 
incubated for 15 min at 60°C and then for 5 min at 100°C. The immuno- 
isolated proteins were analyzed by SDS-PAGE in 7.5% acrylamide accord­
ing to Laemmli (4l). For autoradiography, the gels were dried and exposed 
at -70°C  with preflashed X-ray film (Kodax X-Omat).
Fluorimetric Enzyme Assay. The specificity of ASD-4 for APA and ASD- 
36 for DPP IV was determined by a solid-phase immunodepletion proce­
dure as described (7,42), The purified MAb was first coupled to cyanogen 
bromide-activated Sepharose 4B (S4B) according to the instructions of the 
manufacturer (Pharmacia; Uppsala, Sweden). Briefly, 5 mg of the selected 
MAb in 1 ml of 0.1 M carbonate buffer, pH 8.4, containing 0.5 M NaCl, 
was added per ml of S4B. Residual binding sites were saturated with 1 M 
ethanolamine. A brush border suspension solubilized in 1% Doc contain­
ing 4 mg protein was dissolved in 5 ml buffer (20 mM Tris-HCl, pH 8.4, 
containing 0.1% Doc) and was incubated for 17 hr at 4°C under constant 
stirring with 1 ml of S4B coupled with MAb. In a control experiment, a 
brush border solution was incubated with S4B beads to which no MAb 
had been coupled. The supernatant was removed and the beads were washed 
several rimes with buffer. Elution of the antigen bound to 1 ml of beads 
was performed with 5 ml of 50 mM diethylamine containing 0.1% sodium 
deoxycholate, pH  11,5, for 5 min. The eluted proteins were neutralized 
with 2 M Tris, pH 7.4. The enzymatic activities for APA, DPP IV, and APN 
were measured fluorime tricall y in the control brush border-Doc solution, 
the immunodepleted solution, and the eluate, using L-glutamic acid-a-7- 
amido-4-methylcoumarin (Glu.AMC), glycyl-L-proline-7-amido-4-methyl- 
coumarin-HBr (Gly.Pro.AMC; both from Bachem, Bubendorf, Switzer­
land), and L-alanine-7-amido-4-methylcourmarin (Ala.AMC; from Serva, 
Heidelberg, Germany) as specific and sensitive substrates for APA, DPP 
IV, and APN, respectively (43). For determination of APA activity, the three 
fractions and the substrates were solubilized in 0.1 M Tris-HCl buffer con­
taining 1.25 mM CaCh, pH 7.0. For APN activity, 0.1 M Tris-HCL buffer, 
pH  7.0, and for DPP IV activity 0.1 M Tris-HCl buffer, pH 8.0, were used 
as solutions. Ten fj.1 of one of the three fractions was incubated with 100 
\i\ of one of the three substrates (2 -10“^  M) for 20 min at 37°C. The reac­
tion was stopped by addition of 890 [i\ of 0.2 M Tris-NaOH, pH 11. The 
enzyme activities were determined by the fluorescence of 7-amino-4-methyl- 
coumaiin cleaved from the substrates (43). The fluorescence was mea­
sured at 375 nm (excitation) and 440 nm (emission) using a luminescence 
spectrometer (LS5; Perkin Elmer, Norwalk, CT). The enzyme activities of 
the various fractions are expressed as nkatal/ml, 1 nkatal being the amount 
of enzyme that converts 1 nmol of substrate/sec under the given assay con­
ditions, or as percentages of the activities present in the control brush bor­
der solution.
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Indirect Immunofluorescence. Because in preliminary studies we had 
found no differences in the localization of both hydrolases between male 
and  female mice, except for the reproductive organs, we present the local­
ization found in male mice. Fragments of organs from a 2-month-old male 
Balb/c mouse, as listed In Table 1, were snap-frozen in liquid nitrogen. For 
indirect IF of the female reproductive organs, a 2-month-old female Balb/c 
mouse was used. Two jim-thick, acetone-fixed cryostat sections were in­
cubated with MAbs ASD-4 and ASD-36 for 30 min at room temperature. 
Binding of the two MAbs to the various tissues was visualized with FITC- 
labeted goat anti-rat IgG containing 1.5% normal mouse serum (Cap- 
pel-O tganon Teknika). We differentiated in some organs the presence of 
both hydrolases from B-cells or endothelial cells by additional double labeling 
experiments in which incubation of ASD-4 or ASD-36 was followed by in­
cubation of TRITC-labeled goat anti-mouse Ig for identification of B-cells 
or of the TRITC-conjugated lectin Griffonia simplicifolia (Sanbio; Uden, 
The Netherlands), which identifies specifically mouse endothelial cells (44). 
To define more precisely in the thymus the presence of APA, sections were 
double  labeled with ASD-4 (APA) and a mouse MAb to cytokeratin 2/8 
{RCK 102) (45). The thymic sections were first incubated with ASD-4 diluted 
1:100 in PBS/1% BSA, washed, and incubated with FITC-Iabeled goat anti-rat 
Ig G  diluted 1:25. After this binding the sections were preincubated with 
rab b it  anti-mouse IgG diluted 1:100 in PBS/1% BSA, followed by a short 
wash in PBS. The sections were then incubated with an MAb against cytoker­
a t in  and washed again in PBS. TRITC-labeled rabbit anti-mouse IgG (ITK 
Diagnostics; Uithoorn, The Netherlands) was diluted 1:100 in PBS/1% BSA, 
a n d  washed in PBS. Ail sections were embedded in Aquamount (BDH 
Chemicals, Poole, UK), and examined in a fluorescence microscope equipped 
w ith  Ploemopak Epi-illumination (Leitz; Wetzlar, Germany). The stain­
in g  intensity was recorded semiquantitatively on a scale from 0 to 4 + , as 
described previously (9).
Enzyme Histochemistry. To correlate the localization of APA and DPP 
IV protein in the kidney and thymus with their enzymatic activities, we 
examined the enzymatic activities with specific substrates by the enzyme 
histochemistry technique. For enzyme histochemistry, a kidney and a thy­
m us from a young Balb/c mouse were removed and snap-frozen in liquid 
nitrogen. For demonstration of APA and DPP IV activity, 5 nm-thick, 
acetone-fixed sections were incubated for 10 min for the kidney and for 
30 -45  m in for the thymus at 37°C in substrate buffer containing 100 mM 
Tris-HCl, pH 7.0, 2 mM CaCh, 1.1 mM Fast Blue salt (Serva) 1.6 mM L-glu­
tamic acid-a-methoxy-(3-naphtylarnide for APA, or 1.6 mM glycyl-L-proline- 
a-methoxy-p-naphtylamide for DPP IV (Bachem). After rinsing with PBS, 
th e  sections were embedded in Aquamount and examined by conventional 
light microscopy.
Immunoelectron Microscopy. The localization of APA and DPP IV in 
a restricted number of organs, i.e., kidney, liver, small intestine, thymus, 
and  lung of a normal Balb/c mouse, was examined by indirect immuno- 
electron microscopy (IEM) using immunoperoxidase labeling on 20-nm frozen 
sections. A Balb/c mouse was first perfused retrogradely via the aorta with 
PBS for 5 min and subsequently with a mixture of 10 mM periodate, 75 
mM lysine, and 2% paraformaldehyde, pH 6.2 (PLP) for 10 min (6). The 
organs selected for IEM were removed and small pieces were further fixed 
by immersion for an additional 3 hr in PLP. After rinsing several times in 
PBS, the fragments were cryoprotected by immersion in 2.3 M sucrose, pH  
7.2, for 1 hr, and then frozen in liquid nitrogen. Twenty nm-thick sections 
were rinsed in PBS for 1 hr, then incubated with MAbs ASD-4 and ASD- 
36 diluted in PBS containing 1% BSA for 18 hr at 4°C, followed, after sev­
eral washes with PBS, by incubation for 1.5 hr with a peroxidase-labeled 
rabbit anti-rat IgG diluted in PBS containing 1% BSA and 2% normal 
mouse serum. After three washes in PBS, the sections were incubated in 
PBS, p H  7.4, containing diaminobenzidine (DAB) medium for 10 min,
followed by DAB with addition of 0.003% H 2O 2 for 7 min. The sections 
were washed in distilled water, postfixed in palade buffer containing 1% 
OsO<i for 30 min at 4°C, dehydrated, and embedded in Epon 812. Thin 
sections were prepared on a LKB ultratome (LKB Instruments; Bromma, 
Sweden) and examined by electron microscopy (JEOL1200EX2; JEOL, Tokyo, 
Japan).
Results
Characterization o f  the MAbs
The two rat MAbs that were selected for this study, ASD-4 and 
ASD-36, were o f the IgGi and IgGjb subclass, respectively (7 ). The 
molecular weights of the antigens isolated by the MABs in the solid 
phase immunoisolation technique on radiolabeled preparations of 
renal corpuscles, renal brush borders (Figure 1), and thymus (Fig­
ure 2) were determined by SDS-PAGE under reducing conditions. 
ASD-4 precipitated a protein of 140 KD from both renal brush 
borders (Figure 1, Lane 1) and thymus (Figure 2, Lane 1), represent­
ing the monomeric form of APA as described earlier (23,24,46). 
The monomeric APA protein in renal corpuscles had a higher mo­
lecular weight of 163 KD (Figure 1, Lane 2). A high molecular weight 
protein of more than 200 KD was also seen in renal corpuscles and 
renal brush borders (Figure 1, Lanes 1 and 2), and thymus (Figure
2, Lane 1), representing the intact homodimer of APA that resisted 
the reducing conditions as described previously (23). ASD-36 iso­
lated a protein of 116 KD from both renal corpuscles (Figure 1, Lane 
5) and thymus (Figure 2, Lane 2), representing the monomeric DPP 
IV form (23)* The monomeric DPP IV form from renal brush borders 
had a lower molecular weight o f 103 KD (Figure 1, Lane 4). In con­
trol experiments using normal rat serum instead of MAbs no pro­
teins were isolated from the radiolabeled renal corpuscles and re­
nal brush borders (Figure 1, Lanes 3 and 6). An additional low 
molecular weight-protein of 43 KD was precipitated by both ASD-
4 and ASD-36 from the thymus (Figure 2, Lane 2), renal corpus­
cles, and renal brush borders (data not shown). The protein recog­
nized by ASD-36 is most probably the enzyme adenosine deaminase 
(47), and the band isolated by ASD-4 is actin that co-precipitated 
with APA (48). These immunoprécipitation experiments show that 
there are differences in molecular weight of APA as well as DPP 
IV from different organs (kidney vs thymus), and from different 
structures within the same organ (renal corpuscles vs brush borders).
Specificity of the MAbs
The specificity of the MAbs for the brush border hydrolases APA 
and DPP IV was determined by an immunoadsorption procedure 
using Sepharose-4B beads coated with either ASD-4 or ASD-36 
MAb. Enzymatic activities for APA, DPP IV, and aminopeptidase 
N  (APN; EC 3.4.11.2) detected in the sodium deoxycholate (Doc) 
solubilized brush border fraction using specific substrates in the 
fluorimetric assay were 5.3, 17.1, and 50,7 nkatal, respectively. The 
APA activity was selectively depleted from the brush border-Doc 
solution by ASD-4 (3%), whereas DPP IV activity was selectively 
depleted by ASD-36 (3%) (Figures 3A and B). In both cases, the 
activities for the other two enzymes remained unaltered. Subsc-
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Figure 1. Autoradiogram of the Immunoprécipitation analysis of radiolabeled 
suspensions of mouse renal brush orders (Lanes 1,3, 4, and 6), and renal cor­
puscles (Lanes 2 and 5) after SDS-PAGE (10%) under reducing conditions. 
Lanes 1 and 2 (ASD-4), a rat MAb against mouse A PA; Lanes 4 and 5 (ASD-36), 
a rat MAb against mouse DPP IV; Lanes 3 and 6, normal rat serum, Numbers 
at left indicate the molecular mass of the markers.
4 3
quendy, absorbed enzyme could be recovered from the column by 
elution, The low reactivity of the eluates (25% for APA and 30% 
for DPP IV) is probably due to inactivation of the enzyme caused 
by the elution procedure. The selective depletion of APA activity 
by ASD-4 and of DPP IV activity by ASD-36 indicates that ASD-4 
is directed against APA and ASD-36 is directed against DPP IV.
*
Organ Distribution of APA and DPP IV
By indirect IF and IEM, both APA and DPP IV showed a wide­
spread organ distribution, as summarized in Table 1. In some or­
gans the two enzymes were located on the same cells, such as in 
the cortex of the kidney (Figures 4A and B), small intestine (Figures 
IDA and 10B)t liver (Figures 10E and 10F), various glands, visceral 
yolk sac of the placenta, choroid plexus of the eye (Figure 12F), 
and perineurium, in other organs the enzymes were present in sep­
arate segments of the same epithelium, such as in the uterus, with 
DPP IV predominantly being localized on the inner lining of the 
uterus and APA more on the ductal side o f the epithelium (Figures 
121 and 12J). On the other hand, APA and DPP IV were present 
on separate cells in the thymus (Figures 8 and 9), brain (Figures 
12A and 12B), and spleen and lymph nodes (Figures 12C and 12D). 
In contrast to DPP IV, APA was also found in almost all organs 
on the endothelial cells of capillaries (Figures 4C, 5C, 10C, and
Figure 2. Autoradiogram of the immunopreciptation analysis of radiolabeled 
proteins from mouse thymus after SDS-PAGE (10%) under reducing conditions* 
Lane 1 (ASD-4), a rat MAb against mouse APA; Lane 2 (ASD-36), a rat MAb 
against mouse DPP IV, Numbers at left Indicate the molecular mass of the 
markers.
12 A), but not of arteries and veins, although sometimes a hetero­
geneous distribution was seen, such as in the kidney (Figures 4A 
and 4C). In addition, APA could be found on smooth muscle cells 
of the media of arterioles (Figure 12 C). DPP IV, however, was pres­
ent on cells of serosal cavities (Figure 11D), cells in fibrous capsules 
around many organs, and astrocytes in cerebrum and spinal cord 
(Figure 12B).
In the kidney, APA and DPP IV are co-expressed mainly on iden­
tical cells in the cortex, but not in the medulla. In the glomerulus, 
both enzymes are located on the cell membranes of the podocytes, 
but not on the endothelial or messangial cells as seen by indirect 
IF and IEM (Figures 4A, 4B, 5 A, and 6A). The enzymes were also 
present on the brush borders of the proximal tubule cells, i.e.> APA 
predominantly on the convoluted parts (Si and S2), whereas DPP 
IV was present along the entire proximal tubule (Figures 4A, 4B, 
5B, and 6B). In contrast to DPP IV, APA was observed on the jux­
taglomerular granular cells, the cells of the arteriolar media, and 
endothelial cells of the peritubular capillaries, especially o f the
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Figure 3. Enzymatic activities of APA, DPP IV, and APN measured in two im- 
munodepletion experiments with ASD-4, an MAb against APA (A) and ASD-36, 
an MAb against DPP IV (B) in three fractions using a fluorimetric enzyme as­
say. A detergent-solubilized brush border fraction (T, black bars), a brush bor­
der fraction immunodepleted with ASD-4 or ASD-36 coupled to Sepharose*4B 
beads (A, hatched bars), and a fraction eluted from the beads (E, open bars). 
The enzymatic activities are given as percentages of the activities in the start­
ing material (100%).
each other and were both found on cortical epithelial cells (Figures 
8C, and 8D). APA was not present on cells in the medulla (Figure 
8A). DPP IV was present on cells in the medulla (Figure 8A). DPP 
IV was present on thymocytes, as shown by immunohistological 
staining with ASD-36 and enzyme histochemistry (Figures 8E and 
8F). The expression o f DPP IV varied from cortex to medulla, with 
higher expression in the thymic cortex, corresponding to earlier
reports (49). IEM with ASD-4 showed staining of the cell m em ­
branes of the cortical epithelial cells with its finger-like cell protru­
sions interdigitating between surrounding thymocytes (Figure 9A). 
ASD-36 stained all thymocytes, as shown in Figure 9B. In the pe­
ripheral lymphoid organs, DPP IV was found on T-cells and not 
on B-cells, as examined by double labeling with antibodies to IgM. 
In the spleen these T-cells were located around arterioles, which 
showed the presence of APA on the smooth muscle cells (Figures
12C and 12D).
Both APA and DPP IV were abundantly co-expressed on the 
brush botders of the small intestine, which diffusely stained with 
ASD-4 and ASD-36, respectively, by indirect IF (Figures 10A and 
10B), and IEM (Figure llC). The same co-expression was observed 
in the liver, in which APA and DPP IV were present in various 
amounts on sinusoidal Jining cells, bile canaliculi and, to a lesser 
extent, on hepatocyte/ (Figures 10E and 10F). Their localization 
was more clearly demonstrated by indirect IEM (Figures 11A and 
1 IB). In the lung, as in most other organs, APA was present on 
the endothelial cells o f the alveolar walls. In addition, it could be 
seen on the large Type II alveolar cells, but not on the smaller Type 
I alveolar cells (Figures IOC and HE). DPP IV was mainly located 
on Type I cells (Figures 10D and 11F). In the brain and spinal cord, 
APA was present only on endothelial cells of the capillaries, whereas 
DPP IV was shown on astrocytes (Figures 12A and 12B). Promi­
nent staining with ASD-4 was also seen on follicle cells of the ovary 
and, to a lesser extent, on the cornea (Figures 12K and 12E). Fi­
nally, DPP IV could be found on cells of the islets o f  Langerhans 
(Figure 12H), the epithelium of the Harderian gland of the eye, 
and the germinal epithelium of the ovary.
medulla (Figures 4C and 5B). DPP IV, on the other hand, was found 
on the cells of Henle’s loops, as demonstrated by a double labeling 
IF procedure and by IEM (Figures 4D and 6C). The localization 
of APA and DPP IV, as revealed by immunohistology with ASD-4 
and ASD-36, respectively, matched the enzymatic activities as 
demonstrated by enzyme histochemistry using specific substrates 
(Figure 7).
In contrast to the co-localization of APA and DPP IV in the 
kidney, there was clearly a different expression of the two hydro­
lases on cells in the thymus, spleen, and lymph nodes, suggesting 
different functions related to the development of thymocytes and 
activation o f the T-cells (Figures 8, 12C, and 12D). APA was ex­
pressed only on cortical epithelial cells of the thymus, as confirmed 
in a double labeling experiment with an MAb specific for cytoker- 
atin 2/ 8, which is present only on thymic epithelial cells (Figures 
8A and SB). APA expression, as demonstrated by ASD-4, and its 
enzymatic activity, as shown by enzyme histochemistry, matched
Discussion
This study examined the presence of two important hydrolases, APA 
and DPP IV, in organs of the mouse. This pattern of localization 
might enable us to provide more insight into the various biological 
functions that are attributed to them, APA and DPP IV are well- 
known differentiation markers of lymphoid and myeloid progeni­
tors and are believed to participate in stromal cell-dependent. 
B- and T-cell differentiation and in T-cell activation (23,24,50). In 
general, two ill-defined processes are related to the functions of 
these two enzymes. First, both hydrolases are involved in degrada­
tion and uptake o f  peptides by epithelial cells, such as the cells 
o f the renal proximal tubules and the small intestine. Second, by 
breaking down ligands such as peptide hormones, growth factors, 
cytokines, or other regulatory proteins involved in cell activation, 
growth, and differentiation, APA and DPP IV can reduce or limit 
the cellular response induced by these ligands. It is in this second 
field that some progress has been made in recent years.
APA is a disulfide-linked homodimer that could easily be im-
Table 1. Organ distribution o f APA and DPP lVa
Organ Distribution APA DPP IV
K id n e y G lo m e r u lu s + + + + 4-4-
P ro x im a l  t u b u le s  BB m icrovill i S i + + + + +
S2 + + + + +
S3 + +
D is ta l  t u b u le s — —
L oops o f  H e n le ~ +
P e r i t u b u l a r  capillaries + /  + + —
Pars m e d i a  arteries + + —
J u x t a g lo m e r u l a r  g r a n u l a r  cells + —
C a p su le — + +
Pros ta te E p i th e l i u m _ + +
V esicu lar  g la n d E p i th e l i u m — +
E p id id y m is E p i t h e l i u m -4^ + /  + +
Vas d e fe ren s E p i t h e l i u m — •+*/+ +
O vary G e r m in a l  e p i t h e l i u m — + + / +  +  +
Folicle  cells 4- + + —
O v id u c t E p i t h e l i u m -  /  ± 4- +
U te ru s E p i t h e l i u m -  / ± + + +
C r y p t  e p i t h e l i u m + /  + + + + +
P lacen ta Visceral yolk  sac +  + + +
T o n g u e S erous  g la n d s +  + + +
Sm all in te s t in e D u o d e n u m  BB m icrovilli 4~ 4- + + + +
J e j u n u m  BB microvilli +  + + + + + +
I l e u m  BB m icrovill i 4- +  + + + + +
Large in te s t in e E p i t h e l i u m — /  ± +
Liver S in u so id a l  l i n in g  cells +  4- 4- +
H e p a to c y te s 4" +
Bile  c a n a l ic u lu s 4* 4- + + + +
B ile  d u c t 4- +
G a l lb la d d e r E p i th e l i u m + /  4" 4- ~ / ±
T rach ea S erous  g la n d s + +
L u n g A lv e o la r  w all
E n d o t h e l i u m 4- 4- 4- —
A lv eo la r  cell T y p e  I — + +
A lv eo la r  cell T y p e  II 4- +  + +
P itu i ta ry  g la n d i n t e r m e d i a t e  lo b e + —
A d re n a l  g la n d C o r te x ,  s in u ses 4-4-4*
Salivary g la n d s
P aro t id E p i t h e l i u m + 4" + + +
S u b m a n d ib u l a r E p i t h e l i u m — + +
S u b l in g u a l E p i th e l i u m — 4" +
Pancreas Islets o f  L a n g e rh a n s ± 4- +
E p i t h e l i u m  o f  sm all  d u c ts + + + +
T h y m u s T h y m o c y te s  (T-cells) — + +
C o rt ica l  e p i th e l i a l  cells 4- 4. —
Spleen L y m p h o c y te s  (T-cells) — 4" +
L y m p h  n o d e L y m p h o c y te s  (T-cells) — + +
S in uses 4* —.
Skin H a i r  fo ll ic le  (basis) + 4* + +
Eye C o r n e a 4*
Iris Hh +
C ilia ry  b o d y i +
C h o r o id 4 - 4 - 4 - + +
H a r d e r i a n  g l a n d — +
L acr im al  g l a n d • 4 - 4 - 4 - + + +
C e re b ru m C o r t ic a l  as trocy tes — + + +
C e re b e l lu m P ia  m a t e r — +
S p in a l  cord A strocy tes — 4- +
N erv es P e r i n e u r i u m + + + +
S m o o th  m usc le Pars  m e d i a  a r te r ie s +  + —
M u lt io rg a n C a p i l la ry  e n d o t h e l i u m —
Serosal layer — + + +
C a p s u le  cells — + + +
F ib ro b la s ts + +
^BB, brush border.
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Figure 4. Indirect Immunofluorescence of a 
norma! Balb/c kidney incubated with ASD-4 
(A,C), and ASD-36 (B,D). (A) Incubation with 
ASD-4 caused strong homogeneous bind­
ing along the capillary wall of the glomeru­
lus and the brush borders of the proximal 
tubules. In addition, a faint granular stain­
ing of the juxtaglomerular granular cells is 
present (arrows). (C) In the medulla, ASD-4 
bound strongly to the endothelial cells of the 
peritubular capillaries. (B) ASD-36 also 
strongly stained the glomerular capillary wall 
and the brush borders of the proxima tub­
ules. (D) In the medulla, ASD-36 did not stain 
the endothelial cells of the capillaries, but 
the cells of Henle’s loops were positive as 
detected with a double labeling technique 
using a lectin specific for mouse endothe­
lial cells. Original magnifications: A x 850; 
B x 700; C x 550; D x 400. Bars = 25 \im.
munoprecipitated from the kidney and the thymus by ASD-4. The 
different molecular weights of A PA isolated in this study from re­
nal corpuscles, renal brush borders of proximal tubule epithelial 
cells, and thymus are not the products of different APA isoforms 
but probably reflect differences in glycosylation. Several arguments 
support this presumption. First, the isolated mouse cDNA sequence 
predicts a Type II, 945-amino-acid, integral cell membrane-bound 
protein o f about 108 KD with a large extracellular domain, con­
taining nine possible N-glycosylation sites (51). Second, incuba­
tion of APA with glycolytic enzymes also yielded an identical pro­
tein backbone of almost 110 KD (52) (personal observation). Third, 
Northern blotting experiments on poly A+ RNA from different 
mouse organs always showed a single hybridizing band of approxi­
mately 4 KB (28). APA has a short-18-amino-acid cytoplasmic tail 
that is covalently coupled to actin, as reported by us (48,51), indi­
cating a role of actin in the transport of APA in various cells. APA 
digests N-terminal glutamyl and aspartyl residues from peptides 
(53). APA that is expressed on early B-cells and on stromal cells 
in the bone marrow has an incompletely defined function in early 
B-cell development (51,54,55). One o f the best known functions 
of APA is its regulatory effect on the renin-angiotensin system, 
since APA converts angiotensin II, the most active component of 
this system, into angiotensin III by removal of the N-terminal aspar­
tyl residue (56). Angiotensin II has several effects on the cardiovas­
cular system by its vasopressor and growth-promoting actions. The 
hemodynamic effects in the kidney are related to its regulatory role 
of the renal blood flow, glomerular filtration rate, sodium reab­
sorption in the proximal tubules, and induction of cell growth and 
hypertrophy o f epithelial and muscle cells (57). All of these effects 
are mediated by its binding to several receptors (58,59). It has been
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Figure 5. Indirect immunoelectron microscopy of a normal Balb/c 
kidney incubated with ASD-4, immunoperoxidase labeling. (A) Ho­
mogeneous staining of the ceJI membranes of the podocyte and the 
brush borders of the parietal epithelial cell is seen. The glomerular 
endothelial cell is negative (arrow). Cap, capillary lumen; Pod, podo­
cyte; US, urinary space. (B) Proximal epithelial cell with staining 
of the brush borders. The endothelial cell of the peritubular capil­
lary adjacent to the proximal tubule cell also shows faint staining 
(arrow). Original magnifications: A x 7000; B x 9500. Bars = 2 nm.
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Figure 6. Indirect im mu noelectron microscopy of a normal Balb/c kidney incubated with ASD-36, immunoperoxidase labeling. (A) Diffuse staining of the cell mem­
branes of the podocyte. Glomerular endothelial and mesangial cells are negative. Cap, capillary lumen; Pod, podocyte; US, urinary space (8 ) Proximal tubuie 
cell with homogeneous staining of the brush borders. The endothelial cell of the adjacent capillary is negative. (C) Medulla: homogeneous staining of the cell 
membranes of Henle’s loops (asterisks). The endothelial ceil (arrow) is negative. Original magnifications: A x 6700; B x 5000; C x 2700. Bars *  2 nm.
453
•uni ss = SJB0  “OOfr X uoijeoijjußeiu (BU(6 ijo  ‘setnqni (euiixoid aqi jo sjapjoq qsmq 
©qj jo ßuiurejs aiBjepoiu pus sn|n.iauJO|ß aqi jo Bizméis Buojjs sMoqs eiejjsqns outoeds-/M ddQ e uoHfcqnoui (g) -snotAqo sse) si tfßo|ois!qountuiu! ui uees 
‘seuBiüdêo jejnqruusd aqi jo Bujineis a g i  '(mojjb) Sjjeo j«|nuBj6  je|ruaiuo|ßBpcni eqi ui uees s¡ ßujuiejs jupy ’sn|rueuJO|ß aqi | 0  'luaixa jessej b o\ ‘pue sajnqni 
IBuiixojd aijl )o sjapjoq qsruq eqi jo ßujurejs ßuojjs sMoqs aiejsqns oypads-vdV ue mjM uoiieqnouj (v) 'Aouppf o/qieg jblujou b jo AjjsiLueqooisjq aiuAzu^ */ a jnßy
# Æ ? '  ■■^■9:.
¿¿»¿s.
€* '
'  ï
■% .■ ■' V ;
i :
’■ Í 0 í f
tir .
y .
NMVWSSV ‘3N30M ‘NOS NVA ‘NVWHflQ ‘132XN3W
AMINOPEPTIDASE A AND DIPEPTIDYI PEPTIDASE IV IN MICE 455
/  * » J. >**'} i ; ■ !•*’ • V 1 < -‘fo '-'* s •, ji ?,* y ' '■, • • : •»*. . * 1 • «; ,y\ u*. * rfHfS
■ -7  :t L  \ r v a  '  • • '  , ’ t  ... i *y ' ;  <*•••-• L '  \  < '5 | S - »  : k •' -1 v * . 3*. Jft* V fr v^ v &  *. • ' • ' * • ' ' . - * V\. *  •: -j ••-•'•, •' »• . - /  i
v  - V v  : *  ■ i . ■ #  + ^ . % r ’ ' r , - ,  . * ' / •  . ^ - ' - v  I J
a  * V V ;*/■• •••■ • v. »■;>, ■«:■■■” . v ' :• :fv. •> •: , = & ■ ,  •••: \  • ■ w- v.= - ' f c f r x  ƒ
r \  >./ •*ƒ' ' v> 1 'V. * . 1 4 •: i  - 2  ■ h  < $ g  ■ ' '.••• .'•/, , '• i- ,.••■’ ft. . i f .
V v ,  . . .•' V : : . *V=: ' "  • : •’ 7 -  ' •
.» «
4 .
" I «
» •
. «
pv
I
I
V. /" 'i ff ■ ■
1 '  ms
+ x 7 ‘.
• i *
. >
< »
:V- '
* ' ••■ , v  • ■ •. ' .■•■■•?*' • A \ »■.•=/ • r •■'•-, - ;„■ : -■$<rr 'ly- v ’ ' '  V.-;
• * .  : ■**
s ■'■ ■ • V ' .  ^  . ;  ' •  . 1
•• ~ ^  I *. , '' ■ > *• ’ ’ • i". . s -  ^ '1  >^VvBFÉji, . : ;v>, 7vw . ' ;
i ■ r :■ ' -I ' •'■'  ^^ liK’ : '.li .;.;;ïwV
;: ' ;7 ‘- -■ i j ï ,  ^ /  }  : : V. ,y.
;Æ-;.V - i f i i V V , ' - : : V V . : : '
K 1
«: -t
>
* •• ;-^ ->:^
. . V . .  w , \ . . j
. 4 "  “  •  '  t
■■ , ■: ■ : . •
■ 'V; 1 ■ ■ ■*;.- : • / ' J • • vV' :V .'■*i> ■•''•■. '•'. '  • » ■. • . ,  : ■ '  ■•■: i ••*■ f-j j  • s  M ^ > «. v ;
T2l ' .jr.* * > * *
k r r  ; . o f ' '1 s
t
r ■ V’ - :
.  '  v*--
'  '  v ;  n  .  / '  <  v .  . • .  - .
r  » ■•■?.■ '  1* .v  ■ ‘ ' I
' - !> .  • - .%/;'•• ?;vV*V-; * i
■ : -■".■■. ■<:■ '  ‘  *
• '  ■ •' <? ,', , ,  ^ » r  * • *
y - ' ,  -■
>i ■ r;v> -;^v 
? ;• fe:;. - ■ ,i - •
. ' ■) ' ■•  • 5.! : ' • • , .'• V..‘W>i ■ :*f ■ L, !"■r ■' V- -y<$&'■!? ■ ;■ '\ i  fT-V-..: \ :.,V J  ■ y !"- '
p :■-.-■ ■.  ^ f  ,’*i' / .
" ■ - . . .  . -.Ht- - ' ■ '  ■ ' > ■ ' . ' ■ ■
•  ^  ^ ( w ^  ï / » i • . ^  ^  ’«f ly
k 4 é • * 4 * • ’ • • I * • I s ' ' m '
■ ' ' ' -w  '■ ' 'Aii ■ itc/fiWÎ-^  /'< i
"  f 1 , . '  1 -  ;  vJ •  4 : ' ,  m ? i
!l '{¿r
9B » >
s , ^
tA,4:
-  '  > .  
• .
; v / ' . i  « f  . V « •
V  , ; * v  
t •  . : • * '  / 1 .^: r' « 1 ! <
M  '  «
,-V:!'' ■•■ ■«; ; r ' % <*• « .
Figure 9. Indirect immunoelectron microscopy showing the binding of an MAb against APA (A, ASD-4) and DPP IV (B, ASD-36) to cortical cells of mouse thymus. 
(A) Among negative thymocytes, a dendritic process of an epithelial cell demonstrates staining of the cell membrane. (B) A cluster of round and oval thymocytes 
with relatively large nuclei shows cell membrane staining. Original magnifications: A x 4800; B x 9800, Bars: A = 2 ¿im; B *« 1 nm.
shown that the hemodynamic effects of angiotensin II are regu­
lated via the ATI receptor (60). In the kidney, the presence of the 
ATI receptor is closely associated with the presence of APA, i.e., 
the glomerulus, the juxtaglomerular cells, the proximal tubule ep­
ithelial cells, the endothelial cells of the peritubular capillaries, and 
the arteriolar smooth muscle cells. This supports a regulatory role 
for APA on the actions of angiotensin II in the kidney. Recently, 
we have found evidence for this in an anti-APA-mediated glomer­
ulonephritis in the mouse (7). A single IV injection of ASD-4, an 
MAb that can block the enzymatic activity after binding to APA, 
induces an acute albuminuria that is not dependent on well-known 
systemic mediators, such as complement, platelets, fibrin, neutro­
phils, or monocytes. Treatment with the angiotensin-converting en­
zyme inhibitor enalapril and the ATI receptor antagonist losartan 
considerably reduced this albuminuria, strongly indicating a role 
of angiotensin II in this model (61). We presume that blocking of 
the glomerular APA activity causes a prolonged effect of angioten­
sin II on the glomerular hemodynamics or glomerular filter, lead­
ing to enhanced permeability for proteins. A function of APA in
several forms o f chronic nephropathy is also suggested by others 
who found an association between the extent of the glomerular 
lesions and the reduction o f the APA activity as determined by en­
zyme histochemistry (22).
DDPIV is a heterodimer composed of two noncovalently linked, 
structurally related subunits that could be immunoprecipitated by 
ASD-36 from the kidney and thymus. The different molecular 
weights ranging from 103 to 116 KD, as analyzed in SDS-PAGE un­
der reducing conditions, largely correspond with the state of giycosy- 
lation, as reported (62). The assumption that differences in glycosy- 
lation are the basis for the differences in molecular weight of DPP 
IV is supported by the fact that only a single protein can be precipi­
tated from thymus and kidney (63,64), which is encoded by a sin­
gle cDNA and can be digested with glycolytic enzymes, resulting 
in the predicted 87.5-KD protein backbone (23,50). This is also sup­
ported by the fact that only a single DPP IV RNA isoform has been 
identified in kidney and thymus (62). Nevertheless, it has been 
described that a different cDNA coding for a variant DPP IV iso­
form (DPPX-L) has been cloned from bovine brain, but this iso-
*4—------------------------------------------------------------------------------------------------------------ ---- - -------- - -----------------------------------------------------------------------------
Figure 8. Indirect immunofluorescence and enzyme histochemistry on murine thymus. (A,B). Double staining of 2-jj,m-thick sections of mouse thymus incubated 
with MAbs against APA (A, ASD-4), and against cytokeratin 2/8 (B, RCK 102). Binding of the MAbs is detected by a second FITC-labeled anti-rat and TRITC-labeled 
anti-mouse antibody, respectively. APA is expressed solely on epithelial cells in the cortex of mouse thymus, as evidenced by the identical localization of cytokeratin 
that additionally is expressed in medullary epithelial cells. (C,E). Sections of the cortex of mouse thymus stained with MAbs against APA (C) and DPP IV (E). 
Binding of the MAb Is visualized by an FITC-labeled anti-rat antibody. APA is present on dendrite-like epithelial cells, whereas DPP iV is localized on thymocytes. 
(D,F). Enzyme histochemistry staining of 5-^m-thick section of mouse thymus. Cells in the cortex of the thymus, which were stained with an MAb against APA 
by IF (C), also showed enzyme activity for APA (D) by enzyme histochemistry using an APA-specific substrate. Cortical cells stained with an MAb against DPP 
IV by IF (E) also showed enzyme activity for DPP IV (F) using a DPP IV-specific substrate. Original magnifications: A,B x 125; C -F  x 350. Bars: A,B = 100 nm; 
C-F = 25 nm.
Figure 10. Indirect immunofluorescence of a normal Balb/c intestine (A,B), lung (C,D), and liver (E.F) incubated with ASD-4 (A.C.E) and ASD-36 (B,D,F). (A,B) 
Strong homogeneous binding of the cell membranes of the brush borders of the small intestine after incubation with ASD-4. (A) and ASD-36 (B) ASD-4 stains 
only the endothelial ceils of the lung and the large alveolar cells (arrow) (C). ASD-36 stains predominantly the small alveolar cells (D). In the liver, both ASD-4 
(E) and ASD-36 (F) faintly stain the sinusoidal lining ceils and the bile canaliculi, although staining of these latter structures was stronger after staining with ASD-36. 
Original magnifications: A x 300; B x 260; C,D x 450; E,F x 500. Bars « 25 urn.
456
Figure 11. Indirect immunoelectron microscopy of a normal Balbfc liver (A,B), small intestine (C,D), and lung (E,F) incubated with ASD-4 (A,C,E) and ASD-36 
(B,D,F). Immunoperoxldase labeling. Both ASD-4 (A) and ASD-36 (B) stain the cell membranes of the bile canaliculi (arrows), the sinusoidal lining cells (arrow­
heads), and the liver cells (L). ASD-4 diffusely stained the brush borders of the small intestine and some extracellular material (C). In addition, ASD-36 stained 
the mesothelial cells covering the peritoneal cavity (D). Note the many stained vacuoles in the cytoplasm (arrow). Ct, connective tissue. In the lung, the large 
alveolar cells (arrows) and endothelial cells (arrowhead) are stained by ASD-4 (E), whereas ASD-36 binds predominantly to the small alveolar cells (arrow) (F). 
Original magnifications: A x 10,000; B x 4800; C x 4600; D x 12,000; E x 6800; F x 9000. Bars = 2 urn.
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Figure 12. Indirect immunofluorescence of various organs of a normal Balb/c mouse incubated with ASD-4 or ASD-36. (A) Cerebrum; staining of the endothelial 
cells by ASD-4. (B) Cerebrum; ASD-36 stains astrocytes in the cortex, (C) Spleen; ASD-4 stains smooth muscle cells of arterioles (D). Spleen; staining of T-cells 
around the arterioles by ASD-36. (E) Eye; ASD-4 binds to the epithelial and stromal cells of the cornea. (F) Eye; ASD-4 also binds to the choroid plexus (arrow) 
and endothelial cells of the retina. (G) Adrenal; ASD-4 stains sinusoidal lining cells of the cortex. (H) Pancreas; DPP IV is present in the cells of the Langerhans1 
islets. (0 Uterus; ASD-4 stains epithelial cells of the mucosal ducts. (J) Uterus; ASD-36 stains mainly the mucosal cells lining the uterine cavity. (K) Ovary; luteal 
cells of the follicles are positive for ASD-4. (L) Prostate; staining of the epithelial cells of the ducts by ASD-36. Original magnifications: A x 300; B,C x 125; C-F.H-J  
x 250; K x 100; L x 200. Bars: A,C-F,H-J,L » 25 |im; B,G,K -  50 ^m.
form is expressed predominandy in brain (65). Mouse DPP IV cDNA 
predicts a Type II, 760-amino-acid, membrane-bound glycopro­
tein with a calculated size of 87 KD and with a large extracellular 
and a short>cytoplasmic domain (62). It is a multifunctional mole­
cule involved in signal transduction, hydrolysis and uptake of pep­
tides» and cell adhesion. DPP IV is a serine proteinase that N-ter­
minally digests peptides and proteins with penultimate proline 
or alanine residues (66). DPP IV is known to hydroly2e many natu­
ral proline-containing peptides such as cytokines, growth factors, 
hormones, neurotransmitters, and vasoactive components, indicat­
ing its important role in regulatory processes. Many brain, kidney, 
and intestinal peptides contain a penultimate proline or alanine 
residue that makes them susceptible to hydrolysis (23*24). Like A PA, 
DPP IV participates in the final degradation and uptake of proline- 
containing peptides in the renal proximal tubules and small intes­
tine. The necessity of intact DPP IV acdvity in this process was nicely 
demonstrated in the Fischer 344 rat strain, which lacks functional 
DPP IV and shows reduced digestion of proline-containing pep­
tides in kidney and small intestine (67). DPP IV was originally known 
as aT-cell differentiation marker designated as CD26. It is the only 
ectoenzyme that functions as a co-signaling molecule in the pro­
cess of T-cell activation and proliferation (68). For the signaling 
function, the enzymatic activity of DPP IV is not required (69). 
DPP IV, however, is unable to stimulate T-cells by itself but re­
quires the expression of the T-cell receptor (TCR)/CD3 complex 
(70). DPP IV may also function as an auxiliary adhesion molecule, 
because it can bind with low affinity to the extracellular matrix 
components fibronectin and collagen (14,71). Recently, a role for 
DPP IV in the uptake of the human immunodeficiency virus in 
CD4+ T-cells has been proposed (72). Finally, DPP IV appears to
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participate in some forms of membranous glomerulonephritis in 
the mouse and rat (6,8,11-14,16,73,74). However, in contrast to the 
well-defined role of APA in the passive glomerulonephritis in mice, 
the involvement of DPP IV in several experimental forms of glo­
merulonephritis is controversial at the moment and is not well un­
derstood. Using polyclonal and monoclonal anti-mouse DPP IV 
antibodies, we could induce a membraneous glomerulonephritis 
morphologically characterized by granular immune deposits in the 
subepithelial space of the glomerulus and without the involvement 
of systemic mediators. However, wc never could induce a sustained 
enhanced glomerular permeability as seen in our anti-APA model 
or in the Heymann nephritis model in the rat. In the membranous 
glomerulonephritis in the so-called graft-vs-host mice, it was sug­
gested that DPP IV was also involved in the formation of the im­
m une complexes in the glomerulus, but we could not confirm this 
observation (17,18,75). Moreover, the participation of this enzyme 
as an additional antigen next to the Heymann antigen in the in­
duction of the Heymann nephritis is controversial (15,76). The func­
tion of DPP IV in the glomerulus is not fully understood at pres­
ent. It is also not known whether DPP IV acts as an ectoenzyme 
or as an adhesion molecule in the various forms of glomerulone­
phritis.
In the thymus, APA is localized on cortical epithelial cells, 
whereas DPP IV is present on thymocytes. It is known that progen­
itors of T-lymphocytes develop into mature T-cells characterized 
by a rearranged T-celi receptor/CD3 complex and the CD4 or CDS 
molecules, by interacting with a variety of stromal or epithelial cells 
that compose the microenvironment of the thymus (77). It is be­
lieved that these stromal cells in the thymic cortex provide specific 
signals in the T-cell differentiation that starts beneath the subcap- 
sular region and evolves along the cortex to the medulla. Epithe­
lial cells with their cytoplasmic extensions are organized in an 
elaborate network along which the thymocytes migrate during the 
differentiation process. How these stromal cells act on the develop­
m ent of T-cells is not well understood, but it is assumed that cell- 
associated MHC antigens play an important role in this process 
o f maturation, requiring a direct contact between thymocytes and 
stromal cells. The cortical thymocytes that show high CD4+/8+ ex­
pression and no or low TCR expression are submitted to an MHC- 
restricted ''positive" selection and a tolerance-inducing "negative” 
selection before they become a mature T-cell population that recog­
nizes peptides only in the context of self (77-79). Which role APA 
plays in the maturation of thymocytes is completely unknown at 
the moment. DPP IV in the thymus is known as a co-stimulatory 
molecule of thymocytes, possibly in association with other activat­
ing factors such as IL-2 and CD4 or CD8 (64,80). Although the 
strict separation in expression of APA and DPP IV suggests some 
form of counteractive enzymatic activity between the cortical epi­
thelial cells and thymocytes, such an effect remains to be confirmed.
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